Literature DB >> 908023

Temporal acquistion of enhanced fibrinolytic activity by syrian hamster embryo cells following treatment with benzo(a)pyrene.

J C Barrett, B D Crawford, D L Grady, L D Hester, P A Jones, W F Benedict, P O Ts'o.   

Abstract

Following treatment of Syrian hamster embryo cells with benzo(a)pyrene, the time required for the expression of enhanced fibrinolytic activity was examined. For this study, the fibrin-agarose overlay method was developed to distinguish the activity of normal and transformed colonies of hamster cells. Colonies possessing enhanced fibrinolytic activity were not observed one passage (2 weeks after treatment). Morphologically transformed colonies, which exhibited no enhanced fibrinolytic activity, were observed 8 days following treatment. In contrast to these two early changes, cells capable of growth in soft agar were observed much later (6 to 8 weeks after treatment). Untreated Syrian hamster embryo cells generally senesced and did not exhibit enhanced fibrinolytic activity. Approximately 1 of 10 untreated cultures escaped senescence and evolved as a continuous cell line; such cultures frequently exhibited enhanced fibrinolytic activity. These results suggest that the acquisition of enhanced fibrinolytic activity, while perhaps not a cause of neoplastic transformation, may reflect a loss of control of the normal function of the cellular genetic apparatus during the process of transformation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 908023

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

1.  Relationship between somatic mutation and neoplastic transformation.

Authors:  J C Barrett; P O Ts'o
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

2.  Evidence for the progressive nature of neoplastic transformation in vitro.

Authors:  J C Barrett; P O Ts'o
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

3.  Chemical carcinogens produce mutations to ouabain resistance in transformable C3H/10T1/2 Cl 8 mouse fibroblasts.

Authors:  J R Landolph; C Heidelberger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

4.  Neoplastic conversion of preneoplastic Syrian hamster cells: rate estimation by fluctuation analysis.

Authors:  B D Crawford; J C Barrett; P O Ts'o
Journal:  Mol Cell Biol       Date:  1983-05       Impact factor: 4.272

5.  In vitro inhibition of human sarcoma cells' invasive ability by bis(5-amidino-2-benzimidazolyl)methane--a novel esteroprotease inhibitor.

Authors:  D H Cresson; W C Beckman; R R Tidwell; J D Geratz; G P Siegal
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

6.  Functional significance of the ATP-binding cassette transporter B6 in hepatocellular carcinoma.

Authors:  Kishore Polireddy; Hemantkumar Chavan; Bashar A Abdulkarim; Partha Krishnamurthy
Journal:  Mol Oncol       Date:  2011-07-28       Impact factor: 6.603

7.  Chemical carcinogen-mouse mammary tumor virus interactions in cell transformation.

Authors:  D K Howard; J Schlom; P B Fisher
Journal:  In Vitro       Date:  1983-01

8.  Plasminogen activator induction and platelet aggregation by phorbol and some of its derivatives: correlation with skin irritancy and tumor-promoting activity.

Authors:  P J Brynes; R Schmidt; E Hecker
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

9.  Protease-activated "prodrugs" for cancer chemotherapy.

Authors:  P L Carl; P K Chakravarty; J A Katzenellenbogen; M J Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

10.  An evaluation of three pesticides: piritione, supercypermethrin and metolachlor in transformation bioassays of BHK21 and hamster embryo cells.

Authors:  D Slamenová; M Dusinská; A Gábelová; T Bohusová; C Oravec
Journal:  Cell Biol Toxicol       Date:  1992 Oct-Dec       Impact factor: 6.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.